A detailed history of Capital International Sarl transactions in Pfizer Inc stock. As of the latest transaction made, Capital International Sarl holds 296,265 shares of PFE stock, worth $7.92 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
296,265
Previous 253,106 17.05%
Holding current value
$7.92 Million
Previous $7.02 Million 18.03%
% of portfolio
0.26%
Previous 0.24%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $1.09 Million - $1.28 Million
43,159 Added 17.05%
296,265 $8.29 Million
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $4.79 Million - $5.5 Million
-185,032 Reduced 42.23%
253,106 $7.02 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $972,898 - $1.26 Million
37,233 Added 9.29%
438,138 $12.6 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $774,171 - $904,928
24,125 Added 6.4%
400,905 $13.3 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $919,506 - $1.06 Million
25,457 Added 7.25%
376,780 $13.8 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $2.48 Million - $3.22 Million
62,868 Added 21.79%
351,323 $14.3 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $1.66 Million - $2.17 Million
39,808 Added 16.01%
288,455 $14.8 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $2.4 Million - $2.93 Million
54,865 Added 28.31%
248,647 $10.9 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $1.29 Million - $1.54 Million
27,825 Added 16.77%
193,782 $10.2 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $3.57 Million - $4.42 Million
77,996 Added 88.67%
165,957 $8.59 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $2.91 Million - $4.31 Million
70,321 Added 398.65%
87,961 $5.19 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $41,879 - $53,798
-1,067 Reduced 5.7%
17,640 $759,000
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $341,216 - $386,541
-9,502 Reduced 33.68%
18,707 $733,000
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $129,405 - $145,943
-3,864 Reduced 12.05%
28,209 $1.02 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $164,337 - $208,969
4,910 Added 18.08%
32,073 $1.18 Million
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $286,512 - $336,144
9,024 Added 49.75%
27,163 $997,000
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $159,605 - $193,625
5,299 Added 41.27%
18,139 $593,000
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $425,154 - $607,453
-15,729 Reduced 55.06%
12,840 $419,000
Q4 2019

Feb 18, 2020

SELL
$32.92 - $37.36 $86,612 - $98,294
-2,631 Reduced 8.43%
28,569 $1.12 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $188,597 - $211,752
-5,100 Reduced 14.05%
31,200 $1.35 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $292,372 - $333,336
-7,600 Reduced 17.31%
36,300 $1.58 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $517,050 - $627,150
-15,000 Reduced 25.47%
43,900 $0
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $253,945 - $270,732
7,700 Added 15.04%
58,900 $2.14 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $264,853 - $307,266
8,300 Added 19.35%
51,200 $1.82 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $405,772 - $430,538
12,200 Added 39.74%
42,900 $1.55 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $951,700 - $1.05 Million
30,700
30,700 $1.1 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Capital International Sarl Portfolio

Follow Capital International Sarl and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Sarl with notifications on news.